Thrombosis
News
EC approves edoxaban for patients with VTE, NVAF
Image by Andre E.X.
News
Bivalirudin provides no net benefit in PCI, doc says
Photo by Frank C.
Conference Coverage
Nanobody can help treat acquired TTP
Image by Erhabor Osaro TORONTO—Adding the anti-von Willebrand factor nanobody caplacizumab to standard therapy can provide clinical benefits for...
Conference Coverage
CT after unexplained VTE unnecessary, study suggests
Photo by Angela Mary Butler TORONTO—A CT scan of the abdomen and pelvis does not improve cancer detection in people with unexplained venous...
Conference Coverage
Idarucizumab reverses dabigatran’s anticoagulant effects
Key clinical point: The investigational monoclonal antibody idarucizumab reversed the anticoagulant effects of dabigatran. Major finding:...
Conference Coverage
Drug reverses anticoagulant effect of dabigatran
dabigatran in real-world situations. In the RE-VERSE AD trial, idarucizumab normalized diluted thrombin time (dTT) and ecarin clotting time (ECT...
Conference Coverage
Bridge therapy not necessary in AFib, team says
TORONTO—Bridge anticoagulant therapy appears to be unnecessary in patients with atrial fibrillation (AFib) undergoing elective surgery, according...
News
FDA approves antiplatelet drug for PCI patients
Photo courtesy of The Medicines Company The US Food and Drug Administration (FDA) has approved the intravenous antiplatelet agent cangrelor (...
News
SVT may indicate undiagnosed cancers
Image by Andre E.X.
News
Targeting IL-1β could limit damage after joint bleed
Photo by Rhoda Baer ROME, ITALY—Interleukin-1β (IL-1β) is a crucial factor in the development of blood-induced cartilage damage, according to...
News
VTE may cause mental health problems
Photo by Jiri Hodan DUBROVNIK, CROATIA—Results of a large study suggest patients who develop a venous thromboembolism (VTE) may have more mental...